Guanze Medical Information Industry (Holding) Co., Ltd.

SEHK:2427 Voorraadrapport

Marktkapitalisatie: HK$522.5m

Guanze Medical Information Industry (Holding) Beheer

Beheer criteriumcontroles 1/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Xianzhen Meng

Algemeen directeur

CN¥1.3m

Totale compensatie

Percentage CEO-salaris95.5%
Dienstverband CEO3.9yrs
Eigendom CEO74.0%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur2.5yrs

Recente managementupdates

Recent updates

Here's What's Concerning About Guanze Medical Information Industry (Holding)'s (HKG:2427) Returns On Capital

Sep 10
Here's What's Concerning About Guanze Medical Information Industry (Holding)'s (HKG:2427) Returns On Capital

Guanze Medical Information Industry (Holding) (HKG:2427) Has A Pretty Healthy Balance Sheet

Jun 13
Guanze Medical Information Industry (Holding) (HKG:2427) Has A Pretty Healthy Balance Sheet

Guanze Medical Information Industry (Holding) (HKG:2427) Will Pay A Dividend Of CN¥0.021

Apr 25
Guanze Medical Information Industry (Holding) (HKG:2427) Will Pay A Dividend Of CN¥0.021

Guanze Medical Information Industry (Holding)'s (HKG:2427) Dividend Will Be CN¥0.021

Mar 31
Guanze Medical Information Industry (Holding)'s (HKG:2427) Dividend Will Be CN¥0.021

Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

Nov 23
Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

Jun 29
Estimating The Fair Value Of Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427)

There's Reason For Concern Over Guanze Medical Information Industry (Holding) Co., Ltd.'s (HKG:2427) Massive 27% Price Jump

Apr 19
There's Reason For Concern Over Guanze Medical Information Industry (Holding) Co., Ltd.'s (HKG:2427) Massive 27% Price Jump

Analyse CEO-vergoeding

Hoe is Xianzhen Meng's beloning veranderd ten opzichte van Guanze Medical Information Industry (Holding)'s winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

CN¥11m

Mar 31 2024n/an/a

CN¥20m

Dec 31 2023CN¥1mCN¥1m

CN¥28m

Sep 30 2023n/an/a

CN¥23m

Jun 30 2023n/an/a

CN¥19m

Mar 31 2023n/an/a

CN¥18m

Dec 31 2022CN¥161kCN¥120k

CN¥18m

Sep 30 2022n/an/a

CN¥23m

Jun 30 2022n/an/a

CN¥27m

Mar 31 2022n/an/a

CN¥25m

Dec 31 2021CN¥120kCN¥120k

CN¥23m

Dec 31 2020CN¥120kCN¥120k

CN¥29m

Dec 31 2019CN¥120kCN¥120k

CN¥22m

Compensatie versus markt: Xianzhen's total compensation ($USD177.84K) is about average for companies of similar size in the Hong Kong market ($USD234.60K).

Compensatie versus inkomsten: Xianzhen's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Xianzhen Meng (54 yo)

3.9yrs

Tenure

CN¥1,261,000

Compensatie

Mr. Xianzhen Meng is CEO & Chairman of Guanze Medical Information Industry (Holding) Co., Ltd. Meng was appointed as a Director of Guanze Medical Information Industry (Holding) Co., Ltd. on 11 December 20...

Bestuursleden

NaamPositieTenureCompensatieEigendom
Xianzhen Meng
CEO & Chairman3.9yrsCN¥1.26m74.03%
HK$ 386.8m
Zhenyu Guo
Chief Sales Officer & Executive Director3.2yrsCN¥274.00kgeen gegevens
Man Hin Wong
Independent Non-Executive Director1.9yrsgeen gegevensgeen gegevens
Qingyang Meng
Non-Executive Director3.2yrsCN¥109.00kgeen gegevens
Bin Zhao
Independent Non-Executive Director1.9yrsgeen gegevensgeen gegevens
Shiwang Chang
Independent Non-Executive Director1.9yrsgeen gegevensgeen gegevens

2.5yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren bestuur: 2427's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.